<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="other QT-prolonging drugs or those with prolonged QT at baseline.11" exact="Azithromycin" post="(a weak CYP3A4-inhibiting drug) is a macrolide antibiotic that"/>
 <result pre="needs special attention with proper ECG surveillance.12 The effect of" exact="azithromycin" post="on cardiac repolarization is especially enhanced when used in"/>
 <result pre="with virus-receptor binding and shows potential effectiveness as anti-viral therapy." exact="Chloroquine" post="is well known for its modest effect on prolonging"/>
 <result pre="by the human Ether-Ãƒ -go-go-Related Gene) potassium channel blocking capabilities." exact="Chloroquine" post="may also increase the concentration of beta-blockers that are"/>
 <result pre="reason, heart rate and blood pressure should be monitored carefully.13,14" exact="Hydroxychloroquine" post="sulfate, a derivative of chloroquine, is known to be"/>
 <result pre="used experimentally in the treatment of COVID-19 in combination with" exact="azithromycin" post="and antiviral agents.15 Chloroquine and hydroxychloroquine are metabolised by"/>
 <result pre="treatment of COVID-19 in combination with azithromycin and antiviral agents.15" exact="Chloroquine" post="and hydroxychloroquine are metabolised by CYP3A4, and beside the"/>
 <result pre="COVID-19 in combination with azithromycin and antiviral agents.15 Chloroquine and" exact="hydroxychloroquine" post="are metabolised by CYP3A4, and beside the arrhythmic risks,"/>
 <result pre="meta-analysis showed that although there was no significant benefit of" exact="hydroxychloroquine" post="on viral clearance, a significant increase in mortality was"/>
 <result pre="arrest occurred more likely in patients receiving a combination of" exact="hydroxychloroquine" post="and azithromycin (adjusted OR, 2.13 [95% CI, 1.12-4.05]), while"/>
 <result pre="more likely in patients receiving a combination of hydroxychloroquine and" exact="azithromycin" post="(adjusted OR, 2.13 [95% CI, 1.12-4.05]), while the risk"/>
 <result pre="2.13 [95% CI, 1.12-4.05]), while the risk was lower when" exact="hydroxychloroquine" post="or azithromycin were used alone.21 How to accurately measure"/>
 <result pre="CI, 1.12-4.05]), while the risk was lower when hydroxychloroquine or" exact="azithromycin" post="were used alone.21 How to accurately measure the QT"/>
 <result pre="al.Vitro Antiviral Activity and Projection of Optimized Dosing Design of" exact="Hydroxychloroquine" post="for the Treatment of Severe Acute Respiratory Syndrome Coronavirus"/>
 <result pre="2020424. doi: 10.1111/bjh.16749. 11KALETRA(R) oral film coated tablets, oral solution," exact="lopinavir" post="ritonavir oral film coated tablets, oral solution.Product Insert. AbbVie"/>
 <result pre="doi: 10.1111/bjh.16749. 11KALETRA(R) oral film coated tablets, oral solution, lopinavir" exact="ritonavir" post="oral film coated tablets, oral solution.Product Insert. AbbVie Inc."/>
 <result pre="toxicity: an analysis of electrocardiograms in 85 patients treated with" exact="hydroxychloroquine" post="for connective tissue diseases.Rheumatology (Oxford)2007;46:808-810.17202178 16PageRL2nd, O'BryantCL, ChengD, DowTJ,"/>
 <result pre="of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With" exact="Hydroxychloroquine" post="Alone or in Combination With Azithromycin in an Intensive"/>
 <result pre="(COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With" exact="Azithromycin" post="in an Intensive Care Unit.JAMA Cardiol . Published online501,"/>
 <result pre="et al.Risk of QT Interval Prolongation Associated With Use of" exact="Hydroxychloroquine" post="With or Without Concomitant Azithromycin Among Hospitalized Patients Testing"/>
 <result pre="Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant" exact="Azithromycin" post="Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019"/>
 <result pre="DufortEM, UdoT, WilberschiedLA, KumarJ, TesorieroJ, et al.Association of Treatment With" exact="Hydroxychloroquine" post="or Azithromycin With In-Hospital Mortality in Patients With COVID-19"/>
 <result pre="WilberschiedLA, KumarJ, TesorieroJ, et al.Association of Treatment With Hydroxychloroquine or" exact="Azithromycin" post="With In-Hospital Mortality in Patients With COVID-19 in New"/>
 <result pre="electrocardiograms.Heart1920;7:353-70. 29GautretP, LagierJC, ParolaP, HoangVT, MeddebL, MailheM, et al.Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-label"/>
 <result pre="prolongation in coronavirus disease 2019 (COVID-19) patients treated with either" exact="chloroquine" post="or hydroxychloroquine in conjunction with azithromycin: Possible benefits of"/>
 <result pre="coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or" exact="hydroxychloroquine" post="in conjunction with azithromycin: Possible benefits of intravenous lidocaine.HeartRhythm"/>
 <result pre="2020, ISSN 2214-0271, 10.1016/j.hrcr.2020.03.016. 42KimY, KimSY, LeeJS, KongHJ, HanDW.Effect of" exact="dexmedetomidine" post="on the corrected QT and Tp-e intervals during spinal"/>
</results>
